Table 1.
Clinical Characteristics of DIE and Control Patients
| DIE | Control | |
|---|---|---|
| Sample size | n = 22 | n = 12 |
| Age (years)⁎ | 32 ± 1.5 (21–47) | 31.9 ± 1.09 (19–36) |
| Treatments before surgery (no.) | 22 | 2 |
| None | 0 | 9 |
| Estroprogestative agents | – | 1 |
| LHRH agonists | 22 | 1 |
| Duration of treatment (months)† | 11 (4–60) | 6 (2–32) |
| Infertility | 8 | 3 |
| Duration of symptoms (months)† | 48 (12–168) | – |
| Gynecologic symptoms | 22 | – |
| Bowel symptoms | 22 | – |
| Cyclic exacerbation of symptoms | 20 | – |
| C-reactive protein (mg/L)⁎ | 7.55 ± 2.78 (0.09–36.7) | – |
| Biopsy | ||
| Endometrium | 20 | 12 |
| Deep lesion | 21 | – |
⁎
Data are presented as mean ± SD (range).
†
Data are presented as median (range).